A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT

A duodenal sleeve bypass device added to intensive medical therapy for obesity with type 2 diabetes: a RCT

Background: The EndoBarrier® (GI Dynamics Inc., Boston, MA, USA) is an endoluminal duodenal–jejunal bypass liner developed for the treatment of patients with obesity and type 2 diabetes mellitus. Meta-analyses of its effects on glycaemia and weight have called for larger randomised controlled trials...

Full description

Bibliographic Details
Main Authors: Aruchuna Ruban, Michael A Glaysher, Alexander D Miras, Anthony P Goldstone, Christina G Prechtl, Nicholas Johnson, Jia Li, Madhawi Aldhwayan, Ghadah Aldubaikhi, Ben Glover, Joanne Lord, Olu Onyimadu, Emmanuela Falaschetti, Natalia Klimowska-Nassar, Hutan Ashrafian, James Byrne, Julian P Teare
Format: Article
Language:English
Published: NIHR Journals Library 2020-11-01
Series:Efficacy and Mechanism Evaluation
Subjects:
obesity
type 2 diabetes mellitus
endobarrier
duodenal–jejunal bypass sleeve
duodenal–jejunal bypass liner
Online Access:https://doi.org/10.3310/eme07060

Internet

https://doi.org/10.3310/eme07060

Similar Items